A
77.36
0.66 (0.86%)
| Penutupan Terdahulu | 76.70 |
| Buka | 76.80 |
| Jumlah Dagangan | 279,298 |
| Purata Dagangan (3B) | 462,324 |
| Modal Pasaran | 1,737,363,840 |
| Harga / Pendapatan (P/E TTM) | 48.35 |
| Harga / Pendapatan (P/E Ke hadapan) | 8.70 |
| Harga / Jualan (P/S) | 1.84 |
| Harga / Buku (P/B) | 3.29 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 27 Feb 2026 |
| Margin Keuntungan | -3.12% |
| Margin Operasi (TTM) | 7.61% |
| EPS Cair (TTM) | -1.18 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 43.40% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -13.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 142.03% |
| Nisbah Semasa (MRQ) | 2.66 |
| Aliran Tunai Operasi (OCF TTM) | 80.74 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 39.80 M |
| Pulangan Atas Aset (ROA TTM) | 0.82% |
| Pulangan Atas Ekuiti (ROE TTM) | -4.57% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | ANI Pharmaceuticals, Inc. | Menaik | Menaik |
AISkor Stockmoo
1.4
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | -2.0 |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 1.40 |
|
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 11.08% |
| % Dimiliki oleh Institusi | 100.39% |
| Julat 52 Minggu | ||
| Median | 124.00 (60.29%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Guggenheim | 16 Jan 2026 | 124.00 (60.29%) | Beli | 84.83 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| CAREY STEPHEN P. | 77.15 | 74.75 | 12,148 | 957,564 |
| COOK MEREDITH | 77.15 | 73.90 | 12,340 | 957,085 |
| DAVIS KRISTA | 77.15 | 73.90 | 9,255 | 719,077 |
| GASSERT CHAD | 77.15 | 73.90 | 8,895 | 693,468 |
| GUTWERG ORI | 77.15 | 75.00 | 8,688 | 679,660 |
| LALWANI NIKHIL | 77.15 | 73.90 | 63,375 | 4,929,087 |
| MUTZ CHRISTOPHER | 77.15 | 74.56 | 18,668 | 1,448,259 |
| ROWLAND THOMAS ANDREW | 77.15 | 73.90 | 5,393 | 418,111 |
| SHANMUGAM MUTHUSAMY | 77.15 | - | 11,116 | 857,599 |
| WALSH PATRICK D | - | 76.10 | -6,000 | -456,600 |
| Jumlah Keseluruhan Kuantiti Bersih | 143,878 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 11,203,310 | |||
| Purata Pembelian Keseluruhan ($) | 77.15 | |||
| Purata Jualan Keseluruhan ($) | 74.52 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| CAREY STEPHEN P. | Pegawai | 05 Mar 2026 | Jual (-) | 7,312 | 75.60 | 552,787 |
| CAREY STEPHEN P. | Pegawai | 05 Mar 2026 | Pelaksanaan pilihan | 3,312 | - | - |
| WALSH PATRICK D | Pengarah | 03 Mar 2026 | Jual (-) | 6,000 | 76.10 | 456,600 |
| GUTWERG ORI | Pegawai | 03 Mar 2026 | Jual (-) | 2,060 | 76.10 | 156,766 |
| MUTZ CHRISTOPHER | Pegawai | 02 Mar 2026 | Jual automatik (-) | 417 | 75.22 | 31,367 |
| CAREY STEPHEN P. | Pegawai | 28 Feb 2026 | Dibuang (-) | 2,773 | 73.90 | 204,925 |
| COOK MEREDITH | Pegawai | 28 Feb 2026 | Dibuang (-) | 1,555 | 73.90 | 114,915 |
| DAVIS KRISTA | Pegawai | 28 Feb 2026 | Dibuang (-) | 1,555 | 73.90 | 114,915 |
| GASSERT CHAD | Pegawai | 28 Feb 2026 | Dibuang (-) | 2,221 | 73.90 | 164,132 |
| GUTWERG ORI | Pegawai | 28 Feb 2026 | Dibuang (-) | 2,221 | 73.90 | 164,132 |
| LALWANI NIKHIL | Pegawai | 28 Feb 2026 | Dibuang (-) | 12,217 | 73.90 | 902,836 |
| MUTZ CHRISTOPHER | Pegawai | 28 Feb 2026 | Dibuang (-) | 2,221 | 73.90 | 164,132 |
| ROWLAND THOMAS ANDREW | Pegawai | 28 Feb 2026 | Dibuang (-) | 628 | 73.90 | 46,409 |
| CAREY STEPHEN P. | Pegawai | 26 Feb 2026 | Diperolehi (+) | 22,233 | 77.15 | 1,715,276 |
| COOK MEREDITH | Pegawai | 26 Feb 2026 | Diperolehi (+) | 13,895 | 77.15 | 1,071,999 |
| DAVIS KRISTA | Pegawai | 26 Feb 2026 | Diperolehi (+) | 10,810 | 77.15 | 833,992 |
| GASSERT CHAD | Pegawai | 26 Feb 2026 | Diperolehi (+) | 11,116 | 77.15 | 857,599 |
| GUTWERG ORI | Pegawai | 26 Feb 2026 | Diperolehi (+) | 12,969 | 77.15 | 1,000,558 |
| LALWANI NIKHIL | Pegawai | 26 Feb 2026 | Diperolehi (+) | 75,592 | 77.15 | 5,831,923 |
| MUTZ CHRISTOPHER | Pegawai | 26 Feb 2026 | Diperolehi (+) | 21,306 | 77.15 | 1,643,758 |
| ROWLAND THOMAS ANDREW | Pegawai | 26 Feb 2026 | Diperolehi (+) | 6,021 | 77.15 | 464,520 |
| SHANMUGAM MUTHUSAMY | Pegawai | 26 Feb 2026 | Diperolehi (+) | 11,116 | 77.15 | 857,599 |
| Papar semua | ||||||
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 Jan 2026 | Pengumuman | ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities |
| 06 Jan 2026 | Pengumuman | ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |